Detail

Keywords

Esophageal Achalasia; Fundoplication; gastric cancer; Gastroesophageal Reflux; oesophageal cancer; Upper Gastrointestinal Tract

Research group(s)

• Gastro-esophageal cancer program
  Members:
  Sebastian Schoppmann
  Gerd Jomrich

Selected publications

1. Kollmann, D. et al., 2017. Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma. Annals of Surgical Oncology. Available at: http://dx.doi.org/10.1245/s10434-017-5858-7.
2. Paireder, M. et al., 2017. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. European Journal of Surgical Oncology (EJSO), 43(2), pp.478-484. Available at: http://dx.doi.org/10.1016/j.ejso.2016.11.015.
3. Kristo, I., Riegler, M. & Schoppmann, S., 2015. Should antireflux surgery be considered after successful endoscopic treatment of Barrett�s esophagus with dysplasia and early cancer? Endoscopy, 48(01), pp.92-92. Available at: http://dx.doi.org/10.1055/s-0034-1393166.
4. Drahos, J. et al., 2015. MicroRNA Profiles of Barrett�s Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium. Cancer Epidemiology Biomarkers & Prevention, 25(3), pp.429-437. Available at: http://dx.doi.org/10.1158/1055-9965.EPI-15-0161.
5. Schwameis, K. et al., 2013. Surgical treatment of GIST - An institutional experience of a high-volume center. International Journal of Surgery, 11(9), pp.801-806. Available at: http://dx.doi.org/10.1016/j.ijsu.2013.08.016.